Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Vilin Bio Med Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Vilin Bio Med Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vilin Bio Med - Updates

    12 May 2025, 4:27PM Vilin Bio Med Limited has informed the Exchange regarding 'Non-applicability of Regulation 24A of the SEBI (LODR) Regulations 2015'.
  • Vilin Bio Med - Board Meeting Intimation

    10 May 2025, 3:25PM VILIN BIO MED LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2025 to inter-alia consider and approve the Audited Financial
  • Vilin Bio Med - Public Announcement-Open Offer

    24 Apr 2025, 11:26AM AFCO Capital India Private Limited has Submitted to the Exchange a copy of detailed public announcement in accordance with provisions of the Regulatio
  • Vilin Bio Med has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 9:30PM As of March 2025, <p align=justify> Top five Promoters holding highest number of shares of Vilin Bio Med company are Venkata Bhagi Rao Sadhanala (45.
  • Vilin Bio Med - General Updates

    16 Apr 2025, 10:34PM Vilin Bio Med Limited has informed the Exchange about General Updates
  • Vilin Bio Med - Structural Digital Database

    15 Apr 2025, 4:02PM STRUCTURAL DIGITAL DATA BASE
  • Vilin Bio Med - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    12 Apr 2025, 3:31PM Vilin Bio Med Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Vilin Bio Med - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    10 Apr 2025, 4:36PM Vilin Bio Med Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q4 FY 2024-25
  • Vilin Bio Med - General Updates

    4 Apr 2025, 8:09PM Vilin Bio Med Limited has informed the Exchange about General Updates
  • Vilin Bio Med - General Updates

    4 Apr 2025, 7:56PM Vilin Bio Med Limited has informed the Exchange about General Updates
  • Vilin Bio Med - Public Announcement-Open Offer

    4 Apr 2025, 12:30PM AFCO Capital India Private Limited has Submitted to the Exchange a Copy of corrigendum to the public announcement dated March 27, 2025 for the attenti
  • Vilin Bio Med - Disclosure of material issue

    2 Apr 2025, 6:17PM Vilin Bio Med Limited has informed regarding Disclosure of material issue
  • Vilin Bio Med - Disclosure of material issue

    2 Apr 2025, 5:41PM Vilin Bio Med Limited has informed regarding Disclosure of material issue
  • Vilin Bio Med - General Updates

    1 Apr 2025, 6:08PM Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
  • Vilin Bio Med - Trading Window-XBRL

    28 Mar 2025, 5:30PM VILIN BIO MED LIMITED has informed the Exchange about Closure of Trading Window
  • Vilin Bio Med - Trading Window

    28 Mar 2025, 5:23PM Vilin Bio Med Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20
  • Vilin Bio Med - Public Announcement-Open Offer

    28 Mar 2025, 8:44AM AFCO Capital India Private Limited has submitted to the Exchange a copy of Public Announcement in relation to an open offer to the Public Shareholders
  • Vilin Bio Med - General Updates

    22 Feb 2025, 12:06PM Vilin Bio Med Limited has informed the Exchange about General Updates

Key fundamentals

Evaluate the intrinsic value of Vilin Bio Med Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 25.6368 29.6699 15.6088 12.6957 12.8784
Liabilities 25.6368 29.6699 15.6088 12.6957 12.8784
Equity 13.95 13.95 9.95 3.3 3.3
Gross Profit 0.7868 0.8167 2.5733 0.7659 0.8566
Net Profit 0.2235 0.1624 1.245 0.0335 0.1213
Cash From Operating Activities -3.8304 -5.2998 -1.6584 0.2086 -1.0018
NPM(%) 1.5 1.02 10.11 0.29 1.03
Revenue 14.8099 15.8049 12.313 11.2149 11.7152
Expenses 14.0231 14.9882 9.7397 10.449 10.8586
ROE(%) 0.96 0.7 5.39 0.14 0.52

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vilin Bio Med Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.15 -0.84 26.88 0.00 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.06 0.78 308.58 0.00 14.01 0.68
Vaishali Pharma Ltd 12.85 -1.15 428.33 0.00 2.76 0.00
Astec Lifesciences Ltd 701.25 -1.59 0.00 0.00 -687.11 0.00

Company Info

The Company was originally incorporated as a public limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies, Andhra Pradesh, Hyderabad dated June 29, 2005 with the name `Vilin Bio Med Limited'. We received a certificate of commencement of business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The corporate identification number is U24230TG2005PLC046689. The Promoters of the Company are Viswa Prasad Sadhanala, Sadhanala Venkata Rao, D. Srinivasa Reddy And Ramesh Reddy Sama.Major Events and Milestones :2005- Company Incorporation2006- First Commercial production2007- Expansion of Phase2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections2010- We have received more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio.2012- 120 different styles of Packings including physician sample packs to meet all types packing requirements in the market2014- Added the Sachet section in Non-Beta Lactum facility2015- More than 20 different Punches in different dimensions of the tablet including size and volume to meet all the customer requirements2021- New Promoters are inducted to strengthen the Management of the Company2022- Company appointed Professionals on the Board to strengthen the Board and Corporate Governance.

The Company was originally incorporated as a public limited company under the Companies Act, 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies, Andhra Pradesh, Hyderabad dated June 29, 2005 with the name `Vilin Bio Med Limited'. We received a certificate of commencement of business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The corporate identification number is U24230TG2005PLC046689. The Promoters of the Company are Viswa Prasad Sadhanala, Sadhanala Venkata Rao, D. Srinivasa Reddy And Ramesh Reddy Sama.Major Events and Milestones :2005- Company Incorporation2006- First Commercial production2007- Expansion of Phase2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections2010- We have received more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio.2012- 120 different styles of Packings including physician sample packs to meet all types packing requirements in the market2014- Added the Sachet section in Non-Beta Lactum facility2015- More than 20 different Punches in different dimensions of the tablet including size and volume to meet all the customer requirements2021- New Promoters are inducted to strengthen the Management of the Company2022- Company appointed Professionals on the Board to strengthen the Board and Corporate Governance.

Read More

Parent Organisation

Vilin Bio Med Ltd.

Founded

29/06/2005

Managing Director

Mr.Viswa Prasad Sadhanala

NSE Symbol

VILINBIOST

FAQ

The current price of Vilin Bio Med Ltd is

The 52-week high for Vilin Bio Med Ltd is

The market capitalization of Vilin Bio Med Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vilin Bio Med Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vilin Bio Med Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vilin Bio Med Ltd shares.

The CEO of Vilin Bio Med Ltd is Mr.Viswa Prasad Sadhanala, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT